Doug Farrar

Doug Farrar is a co-founder of MenoGeniX and has over 30 years of biotech industry experience. Doug spent 18 of those 30 years with Amgen, starting as a process development engineer in 1987 when the company had 250 employees.

Prior to Amgen, Doug worked for Monsanto in their biotech animal health division, and after Amgen worked as senior vice president of operations for Insmed, and later as a chief technical officer of Coherus. Throughout his career, Doug has successfully worked with numerous corporate partners in the U.S., Europe, and Japan. He has extensive experience in process development, clinical manufacturing, and commercial manufacturing. His previous responsibilities include cell-line development, cell banking, fermentation/cell culture, purification, fill/finish, lyophilization, outsourced manufacturing, engineering, and logistic operations. Farrar has been involved in filing 16 Investigational New Drug (IND) Applications and two Biological License Applications (BLAs). Doug has worked with dozens of products developed by recombinant DNA technology in microbial, yeast, and mammalian cells manufactured in-house or at contract manufacturing facilities, and has built a process development pilot plant and multi-product clinical manufacturing plant from the ground up, as well as expanded, renovated and retooled commercial manufacturing facilities with hundreds of kilograms to multi-metric ton output capabilities. Doug has hosted numerous US FDA, European, and Health Canada prior approval and periodic inspections, and has been involved in many Pre-IND, EOP2, Pre-BLA, Post-Approval Change, Type C, and similar meetings with the FDA, MHRA, EMEA, and other regulatory agencies. Doug received a Bachelor of Science in chemical engineering from the University of Missouri, Rolla (now known as Missouri University of Science and Technology) in 1986.